National Symposium on Bone Marrow Failure Syndromes Partners

We would like to acknowledge and extend our sincere gratitude to our partners for their support and contribution towards this exciting event.

Gold Partner


Alexion is focused on providing innovative treatments to patients with life-threatening rare diseases for which there are few, if any, effective treatment options. Alexion established operations in Sydney in 2008 to serve patients in the Australian region. Alexion aim to work in partnership with stakeholders including healthcare providers, patient advocacy organisations, and government in order to best serve patients. By expanding the knowledge and awareness of rare diseases, Alexion aim to help the medical community improve the process for diagnosis and treatment.

Visit website

Expert Panel and Welcome Reception Partner


Perpetual’s wealth management business has been protecting and growing the wealth of our clients since 1886 – some of our client relationships span five generations.

Today, the business offers a unique mix of wealth management, advice and trustee services to individuals, families, businesses, not-for-profits and Indigenous communities.

Visit website

Silver Partner and Exhibition


Novartis is improving the lives of more than 2.8 million patients across Australia and New Zealand through our medicines. By partnering with the healthcare system we are working for patients to address their needs, and we are committed to accelerating patient access to life saving treatments and associated healthcare.

Visit website


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Visit website

Silver Partner


Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. Based in Melbourne, Gilead Sciences Australia and New Zealand employs over 100 people.


Visit website

St Vincent’s Institute of Research

For more than 60 years, scientists at SVI have been inspired by discovery and driven by purpose.  Our team of 250 staff and students work collaboratively to tackle some of the most critical health challenges facing society today, including cancer, diabetes, osteoporosis, cardiovascular disease, infectious disease and dementia. 

SVI is located on the campus of St Vincent’s Hospital Melbourne, is affiliated with the University of Melbourne, and operates proudly in one of the world’s most dynamic biomedical hubs.  

Visit website

Program Book Partner

Royal Melbourne Hospital Foundation

The Royal Melbourne Hospital is one of the largest and busiest hospitals in Australia, and our team of nearly 10,000 staff treats more than 100,000 inpatients and 200,000 outpatients each year, including more than 30,000 cancer patients. The Royal Melbourne Hospital Foundation works with individual donors, grateful consumers, companies and partner organisations in our community to support the RMH in its mission to advance health for everyone, every day.

Visit website


Link Healthcare

Visit website

Nestle Health Science

Nestle Health Science has products to enhance, maintain and improve health across the spectrum of life.

Visit website


Visit website

Sign up to be the first to hear about our upcoming News & Events